These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6136994)

  • 21. Evidence for adrenergic and tachykinin activity in venom of the stonefish (Synanceja trachynis).
    Hopkins BJ; Hodgson WC; Sutherland SK
    Toxicon; 1996 May; 34(5):541-54. PubMed ID: 8783449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
    Reyes G; Ramírez T; Hong E
    Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
    [No Abstract]   [Full Text] [Related]  

  • 24. [The pharmacology of (+/-)-1-(4-cyclohexylureido-phenoxy)-2-hydroxy-3-tert-butylaminopropane (Talinolol, Cordanum, 02-115)].
    Femmer K; Bartsch R; Leonhardt U; von Littrow C; Riedel H
    Pharmazie; 1975 Oct; 30(10):642-51. PubMed ID: 688
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
    Heer S; Femmer K
    Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
    [No Abstract]   [Full Text] [Related]  

  • 26. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-activity relationships in further series of amino-halogen substituted phenyl-aminoethanols.
    Engelhardt G
    Arzneimittelforschung; 1984; 34(11A):1625-32. PubMed ID: 6152155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
    Kaiser J; Härtfelder G; Lindner E; Schölkens B
    Arzneimittelforschung; 1980; 30(3):420-7. PubMed ID: 6992788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of the new beta-adrenolytic compound propyl-3-acetyl-4-[(2-hydroxy-3-isopropylamino) propoxy]carbanylate hydrochloride on isolated heart muscle.
    Knezl V; Magna D; Sotníková R; Drímal J
    Arzneimittelforschung; 1994 Jan; 44(1):7-12. PubMed ID: 7907875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenergic agents. 4. Substituted phenoxypropanolamine derivatives as potential beta-adrenergic agonists.
    Kaiser C; Jen T; Garvey E; Bowen WD; Colella DF; Wardel JR
    J Med Chem; 1977 May; 20(5):687-92. PubMed ID: 16136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic ethers of cyclohexylphenols with beta-blocking activity: synthesis and pharmacological study of exaprolol.
    Carissimi M; Gentili P; Grumelli E; Milla E; Picciola G; Ravenna F
    Arzneimittelforschung; 1976 Apr; 26(4):506-16. PubMed ID: 8056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of the novel Ca2+-sensitiser EMD 57033 in pigs at rest and during treadmill exercise.
    Stubenitsky R; van der Weerd RW; Haitsma DB; Verdouw PD; Duncker DJ
    Br J Pharmacol; 1997 Dec; 122(7):1257-70. PubMed ID: 9421271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A search for new beta-adrenoblockaders in the series of 5-phenoxymethyl-1,2,4-oxadiazole derivatives].
    Mashkovskiĭ MD; Iuzhakov SD
    Eksp Klin Farmakol; 1994; 57(3):27-30. PubMed ID: 7914114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the synthesis of compounds with beta-adrenergic activity (author's transl)].
    Lehmann D; Eckardt R; Faust G; Fiedler W
    Pharmazie; 1980; 34(5-6):278-84. PubMed ID: 6106206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative studies on beta-adrenolytic potencies of some new phenoxyaminopropanol derivatives and celiprolol.
    Mlynárová R; Racanská E
    Pharmazie; 1997 Mar; 52(3):234-7. PubMed ID: 9109170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Beta-adrenoblocking activity and other pharmacological properties of 2-(3-amino-2-hydroxypropoxy)phenyoxymethyl isoxazole derivatives].
    Iuzhakov SD; Zaĭtseva KA; Dorodnikova EV; Mashkovskiĭ MD
    Farmakol Toksikol; 1985; 48(3):36-40. PubMed ID: 2863169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The specificity of action of penbutolol and propranolol and their optical isomers].
    Kaiser J
    Arzneimittelforschung; 1980; 30(3):427-32. PubMed ID: 6104494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inotropic and beta blocking effects of a chimeric molecule that putatively inhibits both type III phosphodiesterase and beta adrenoceptors in anesthetized dogs.
    Shaffer JE; Grizzle MK; Anderson DK; Wheeler TN
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1105-12. PubMed ID: 8099617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.